top of page
Embryonic Stem Cells


Combination Partner of Choice

We strive to deliver cancer cures. As a locally delivered therapy, AIM is expected to have a favorable tolerability profile that will not burden patients, but will expand patient eligibility and improve outcomes especially for patients with limited treatment options.

Get in touch to learn more.

bottom of page